Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 2/2024

26-02-2024 | Myocarditis | IM - COMMENTARY

Exploring IL-1 inhibition in chronic refractory idiopathic myocarditis: emerging insights and perspectives

Authors: Maddalena Alessandra Wu, Emanuele Bizzi, Antonio Brucato

Published in: Internal and Emergency Medicine | Issue 2/2024

Login to get access

Excerpt

Recent translational research has demonstrated that inflammasome activation and inhibition play a crucial role across a wide spectrum of cardiovascular diseases. These include acute and recurrent pericarditis, myocarditis, acute myocardial infarction, inflammatory cardiomyopathies, as well as heart failure, atherosclerotic cardiovascular disease, and venous thromboembolism [1]. Remarkably, this has emerged as a sort of “common final pathway,” shared by conditions with different etiologies and triggers, capable of significantly impacting acute and long-term outcomes. …
Literature
1.
2.
3.
4.
5.
Metadata
Title
Exploring IL-1 inhibition in chronic refractory idiopathic myocarditis: emerging insights and perspectives
Authors
Maddalena Alessandra Wu
Emanuele Bizzi
Antonio Brucato
Publication date
26-02-2024
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 2/2024
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-024-03552-4

Other articles of this Issue 2/2024

Internal and Emergency Medicine 2/2024 Go to the issue

IM-Point of view

Contrasting obesity: is something missing here?

IM - ORIGINAL

Development and validation of the Medical Attitudes Towards Deprescribing Questionnaire

IM - ORIGINAL

Renal function modifies the association between hemoconcentration and outcomes in hospitalized heart failure patients

CE - MEDICAL ILLUSTRATION

Multiple pancreaticoduodenal artery aneurysms and retroperitoneal bleeding in a patient with celiac artery compression syndrome

IM - ORIGINAL

A multicenter prospective randomized controlled trial investigating the effects of combustion-free nicotine alternatives on cardiovascular risk factors and metabolic parameters in individuals with type 2 diabetes who smoke: the DiaSmokeFree study protocol

IM - ORIGINAL

The role of circulating biomarkers in predicting the 30-day mortality of immune checkpoint inhibitors-related myocarditis: a retrospective cohort study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits